Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy

Overview of attention for article published in OncoTargets and therapy, December 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 216 followers.

See my latest co-authored publication #leusm https://t.co/CO7cwK2obA

Reply Repost Favourite